- Help
- •Contact us
- •About us
- •Sitemap
- •Advertise with the FT
- •Terms & conditions
- •Privacy policy
- •Copyright
© The Financial Times Ltd 2013 FT and 'Financial Times' are trademarks of The Financial Times Ltd.
HEALTH CARE
7:54pm
PHARMACEUTICALS
9:47am
AstraZeneca warns of tough year ahead
Failure of developmental drugs hits 2012 profits
PHARMACEUTICALS
Jan 30, 2013
Roche boosted by robust US sales
Swiss pharma group expects European market to remain weak
HEALTH CARE
Jan 29, 2013
Virgin Care opens clinic in Boots outlet
First of several potential high street openings
- Virgin keeps a low profile in healthcare
- Monday interview Richard Branson
PHARMACEUTICALS
Jan 29, 2013
Pfizer hints core drugs unit may be split
Group in market for ‘bolt-on’ acquisitions
PHARMACEUTICALS
Jan 28, 2013
Sanofi launches talking injection device
Device for people suffering from extreme allergic reactions
Jan 28, 2013
SThree focuses on contracts as profits fall
Recruiter joins in ‘land grabbing’ in markets outside of the UK
PHARMACEUTICALS
Jan 28, 2013
Move to disclose payments to doctors
Concern on potential conflicts of interest sparks public consultation
From
MEDIA
Jan 28, 2013
Demand for restraint to hit bonuses
Many groups also plan to freeze pay
- Whitehall in spin over sugar
- Peter Hetherington HS2 masks north-south gap
Week in Review
from
PHARMACEUTICALS
Jan 25, 2013
Week in Review, January 26
Novartis appoints a friendly German as Huawei pledges to open up
From
RETAIL & CONSUMER
Jan 23, 2013
UK lens market open to more online sales
Consumers slow to see attraction of buying contacts on the web
From
LEX
Jan 23, 2013
Novartis: change at the top
Vasella’s departure could be signal for overdue check-up
PHARMACEUTICALS
Jan 23, 2013
Novartis chairman leaves mixed legacy
Vasella’s expansionist strategy has drawn criticism
PHARMACEUTICALS
Jan 23, 2013
Vasella to step down as Novartis chairman
Reinhardt to replace veteran who led Swiss group for 17 years
PHARMACEUTICALS
Jan 23, 2013
Allergan adds MAP to migraine plans
US maker of Botox in $958m deal for MAP Pharma
From
WORLD
Jan 22, 2013
US healthcare costs seek home remedy
FT series: America’s Debt Dilemma – Richard McGregor on Medicare
From
WORLD
Jan 22, 2013
Dutch health system hopes fall short
Market-based changes resembles ‘Obamacare’ reforms
HEALTH CARE
Jan 22, 2013
J&J pledges growth for consumer business
Recalls have hit reputation of many of US company’s top brands
Multimedia
Offers
JOIN THE BUSINESS ELITEMore people at the top read the FT*
*FT has grown in every major readership survey in 2010
*FT has grown in every major readership survey in 2010 MOST POPULAR NOW ON FT.COM
COMPANIES NEWS ON TWITTER
More FT Twitter accounts
EDITOR’S CHOICE
MOST POPULAR IN COMPANIES
-
Group Finance Director
Dart Group PLC
-
General Manager - Budgeting & Forecasting
Jet2.com
-
Chief Operating Officer (COO)
Scribol, Technology
-
Resources Director
CBI
TOOLS & SERVICES
Multimedia
Tools
- Portfolio
- FT Lexicon
- FT clippings
- Currency converter
- MBA rankings
- Newslines
- Today's newspaper
- FT press cuttings
- FT ebooks
- FT ePaper
- Economic calendar
AstraZeneca: don’t look now
Anglo-Swedish drugmaker’s results reflect how tough the task of restoration will be